Influenza virus neuraminidase alters aiiogeneic T cell proliferation

Virology

Volumn 264, Issue 2, 1999, Pages 427-435

  Oh, Sangkon ^a   Eichelberger, Maryna C ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; SIALIDASE;

ALLOIMMUNITY; ARTICLE; BONE MARROW; CYTOTOXIC T LYMPHOCYTE; ENZYME ACTIVITY; HELPER CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFLUENZA VIRUS; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; VIRUS INFECTION;

EID: 0033604581     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1999.0019     Document Type: Article

References (28)

1. Allan W., Tabi Z., Cleary A., Doherty P. C. Cellular events in the lymph node and lung of mice with influenza. Consequence of depleting CD4+ T cells. J. Immunol. 144:1990;3980-3986.
2. Ardman B., Sikorski M. A., Staunton D. E. CD43 interferes with T-lymphocyte adhesion. Proc. Natl. Acad. Sci. USA. 89:1992;5001-5005.
3. Bonham C. A., Lu L., Li Y., Hoffman R. A., Simmons R. L., Thomson A. W. Nitric oxide production by mouse bone marrow-derived dendritic cells: Implications for the regulation of allogeneic T cell responses. Transplantation. 62:1996;1871-1877.
4. Boog C. J. P., Neefjes J. J., Boes J., Ploegh H. L., Melief C. J. M. Specific immune response restored by alteration in carbohydrate chains of surface molecules on antigen-presenting cells. Eur. J. Immunol. 19:1989;537-542.
5. Chen X-P., Enioutina E. Y., Daynes R. A. The control of IL-4 gene expression in activated murine T lymphocytes. J. Immunol. 158:1997;3070-3080.
6. Couch R. B., Kasel J. A., Six H. R., Cate T. R. The basis for immunity to influenza in man. Nayak D. P., Fox D. F. Genetic Variation Among Influenza Viruses. 1981;535-546 Academic Press, New York.
7. Cowing C., Chapdelaine J. M. T cells discriminate between Ia antigens expressed on allogeneic accessory cells and B cells: A potential function for carbohydrate side chains on Ia molecules. Proc. Natl. Acad. Sci. USA. 80:1983;6000-6004.
8. Cullen S. E., Kindle K. S., Schreffler D. C., Cowing C. Differential glycosylation of murine B cells and spleen adherent cell Ia antigens. J. Immunol. 127:1982;1478-1484.
9. de Smet W., Walter H., van Hove L. A new CD43 monoclonal antibody induces homotypic aggregation of human leucocytes through a CD11a/CD18-dependent and -independent mechanism. Immunology. 79:1993;46-54.
10. Diamond M. S., Staunton D. E., Marlin S. D., Springer T. A. Binding of the integrin Mac-1 (CD11b/CD18) to the third immunoglobulin-like domain of ICAM-1 (CD54) and its regulation by glycosylation. Cell. 65:1991;961-971.
11. Fanales-Belasio E., Zambruno G., Cavani A., Girolomoni G. Antibodies against sialophorin(CD43) enhance the capacity of dendritic cells to cluster and activate T lymphocytes. J. Immunol. 159:1997;2203-2211.
12. Gallart T., Angel de la Fuente M., Josep Barcelo J., Alberola-IIa J., Lozano F. Desialylation of T lymphocytes overcomes the monocyte dependency of pokeweed mitogen-induced T-cell activation. Immunology. 90:1997;57-65.
13. Gubareva L. V., Robinson M. J., Bethell R. C., Webster R. G. Catalytic and framework mutations in the neuraminidase active site of influenza viruses that are resistant to 4-Guanidino-Neu5Ac2en. J. Virol. 71:1997;3385-3390.
14. Lambre C. R., Kazatchkine D. D., Malliet F., Thibon M. Guinea pig erythrocytes after their contact with influenza virus acquire the ability to activate the alternative complement pathway through virus induced desialylation of the cells. J. Immunol. 128:1982;629-634.
15. Lambre C. R., Chauvaux S., Pilatte Y. Fluorometric assay for the measurement of viral neuraminidase in influenza vaccines. Vaccine. 7:1989;104-105.
16. Landolfi N. F., Leone J., Womack J. E., Cook R. G. Activation of T lymphocytes results in an increase in H-2-encoded neuraminidase. Immunogenetics. 22:1985;159-167.
17. Liu C., Air G. M. Selection and characterization of neuraminidase-minus mutant of influenza virus and its rescue by cloned neuraminidase gene. Virology. 194:1993;403-407.
18. Mrkoci K., Kelm S., Crocker P. R., Schauer R., Berger E. G. Constitutively hyposialylated human T-lymphocyte clones in the Tn-syndrome: Binding characteristics of plant and animal lectins. Glycoconjugate J. 13:1996;567-573.
19. Palese P., Tobita K., Ueda M., Compans R. W. Characterization of temperature-sensitive influenza virus mutants defective in neuraminidase. Virology. 61:1974;397-410.
20. Peters J., Swallow D. M., Andrew S. J., Evans L. A gene (Neu-1) on chromosome 17 of the mouse affects acid alpha-glucosidase and codes for neuraminidase. Genet. Res. 38:1981;47-55.
21. Pilatte Y., Bignon J., Lambre C. R. Sialic acids as important molecules in the regulation of the immune system: Pathophysiological implications of sialidases in immunity. Glycobiology. 3:1993;201-217.
22. Rhodes J., Zheng B., Morrison C. A. Galactose oxidation as a potent vaccine adjuvant strategy: Efficacy in murine models and in protection against a bovine parasitic infection. Ann. N. Y. Acad. Sci. 754:1995a;169-186.
23. Rhodes J., Chen H., Hall S. R., Beesley J. E., Jenkins D. C., Collins P., Zheng B. Therapeutic potentiation of the immune system by costimulatory Schiff-base-forming drugs. Nature. 377:1995b;71-75.
24. + T-helper and a T-killer cell. Nature. 393:1998;474-478.
25. Schultz-Cherry S., Hinshaw V. S. Influenza virus neuraminidase activates latent transforming growth factor-beta. J. Virol. 70:1997;8624-8629.
26. Steinman R. M. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 9:1991;271-296.
27. Sumiko T., Nariuchi H. Possible role of neuraminidase in activated T cells in the recognition of allogeneic-Ia. J. Immunol. 141:1988;440-446.
28. Varki A. Sialic acids as ligands in recognition phenomena. FASEB J. 11:1997;248-255.